Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Use of genome-wide association studies for drug repositioning

Nature Biotechnology volume 30, pages 317–320 (2012) Cite this article

Subjects

To the Editor:

Over the past few years, large investments have been made in genome-wide association studies (GWAS) with the expectation that some of these studies would lead to the identification of novel therapeutic modalities or allow selection of patients who would respond better to therapeutic interventions. Although the results have provided valuable biological insights for many common diseases, the translation of the genetics findings from GWAS into the clinic remains limited and a topic of intense debate. Among the factors that could explain this situation are that the road from a gene target to an approved marketed drug takes in general more than ten years and most GWAS results have only been obtained over the past four years. Furthermore, because the effect size of the common variants identified by GWAS, alone or in aggregation, is generally modest, the impact in terms of personalized, individually tailored medicine has been negligible. We present here an analysis of another potential application of GWAS data—drug repositioning. In the following study, we assess the utility of GWAS in systematically and rapidly identifying alternative or refined indications for existing drugs.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Analysis pipeline.
The alternative text for this image may have been generated using AI.

References

  1. Kathiresan, S. et al. Nat. Genet. 40, 189–197 (2008).

    Article  CAS  Google Scholar 

  2. Franke, A. et al. Nat. Genet. 42, 1118–1125 (2010).

    Article  CAS  Google Scholar 

  3. Moschen, A.R. et al. Gut 54, 479–487 (2005).

    Article  CAS  Google Scholar 

  4. Stefansson, H. et al. Nat. Genet. 41, 277–279 (2009).

    Article  CAS  Google Scholar 

  5. Clark, L.N. et al. Eur. J. Hum. Genet. 18, 838–843 (2010).

    Article  CAS  Google Scholar 

  6. Louis, E.D. Lancet Neurol. 4, 100–110 (2005).

    Article  Google Scholar 

  7. Tobacco and Genetics Consortium. Nat. Genet. 42, 441–447 (2010).

  8. Stuart, P.E. et al. Nat. Genet. 42, 1000–1004 (2010).

    Article  CAS  Google Scholar 

  9. Ormerod, A.D. et al. Arch. Dermatol. Res. 290, 3–8 (1998).

    Article  CAS  Google Scholar 

  10. Ormerod, A.D. et al. Br. J. Dermatol. 142, 985–990 (2000).

    Article  CAS  Google Scholar 

  11. Welsh, P. et al. J. Clin. Endocrinol. Metab. 95, 93–99 (2010).

    Article  CAS  Google Scholar 

  12. Xu, K. & Coté, T.R. Brief. Bioinform. 12, 341–345 (2011).

    Article  CAS  Google Scholar 

  13. Nair, R.P. et al. Nat. Genet. 41, 199–204 (2009).

    Article  CAS  Google Scholar 

  14. Styrkarsdottir, U. et al. Nat. Genet. 41, 15–17 (2009).

    Article  CAS  Google Scholar 

  15. Zeggini, E. et al. Science 316, 1336–1341 (2007).

    Article  CAS  Google Scholar 

  16. Imielinski, M. et al. Nat. Genet. 41, 1335–1340 (2009).

    Article  CAS  Google Scholar 

  17. Barrett, J.C. et al. Nat. Genet. 40, 955–962 (2008).

    Article  CAS  Google Scholar 

  18. Anderson, C.A. et al. Nat. Genet. 43, 246–252 (2011).

    Article  CAS  Google Scholar 

  19. Dubois, P.C. et al. Nat. Genet. 42, 295–302 (2010).

    Article  CAS  Google Scholar 

  20. Baratz, K.H. et al. N. Engl. J. Med. 363, 1016–1024 (2010).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank K. Peters for helpful comments on this manuscript. T.P. holds a Canada Research Chair and is supported by the Canadian Institutes of Health Research (CIHR). J.B.R. is supported by the CIHR, Ministere Développement Economique, Innovation et Exportation du Québec, Fonds de la Recherche en Santé du Québec, Lady Davis Institute of Medical Research.

Author information

Author notes

  1. Michael R Barnes & Vincent Mooser

    Present address: Present addresses: William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK and Department of Pathology and Laboratory Medicine, CHUV University Hospital, Lausanne, Switzerland.,

Authors and Affiliations

  1. Computational Biology Department, Quantitative Sciences, GlaxoSmithKline, Stevenage, UK

    Philippe Sanseau, Pankaj Agarwal & Michael R Barnes

  2. Departments of Human and Medical Genetics, McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada

    Tomi Pastinen

  3. Departments of Medicine, Human Genetics, Epidemiology and Biostatistics, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada

    J Brent Richards

  4. Genetics Department, Quantitative Sciences, GlaxoSmithKline, King of Prussia, Pennsylvania, USA

    Lon R Cardon & Vincent Mooser

Authors
  1. Philippe Sanseau
    View author publications

    Search author on:PubMed Google Scholar

  2. Pankaj Agarwal
    View author publications

    Search author on:PubMed Google Scholar

  3. Michael R Barnes
    View author publications

    Search author on:PubMed Google Scholar

  4. Tomi Pastinen
    View author publications

    Search author on:PubMed Google Scholar

  5. J Brent Richards
    View author publications

    Search author on:PubMed Google Scholar

  6. Lon R Cardon
    View author publications

    Search author on:PubMed Google Scholar

  7. Vincent Mooser
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Philippe Sanseau.

Ethics declarations

Competing interests

P.X.S. is a full-time employee of GlaxoSmithKline, a pharmaceutical company.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanseau, P., Agarwal, P., Barnes, M. et al. Use of genome-wide association studies for drug repositioning. Nat Biotechnol 30, 317–320 (2012). https://doi.org/10.1038/nbt.2151

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt.2151

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing